Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Planned sale Chief Legal Officer sold 551 shares at $73.57 ($40,539)
  3. 4 Planned sale Chief Legal Officer sold 114 shares at $76.99 ($8,777)
  4. 4 Planned sale President sold 318 shares at $76.99 ($24,483)
  5. 4 Planned sale Chief Financial Officer sold 162 shares at $78.03 ($12,640)
  6. 4 Planned sale Chief Legal Officer sold 162 shares at $78.03 ($12,640)
  7. 4 Planned sale President sold 300 shares at $78.03 ($23,408)
  8. 4 Planned sale Chief Financial Officer sold 1,321 shares at $79.39 ($104,881)
  9. 4 Planned sale Chief Legal Officer sold 1,319 shares at $79.39 ($104,722)
  10. 4 Planned sale President sold 254 shares at $84.10 ($21,363)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale Director sold 15,000 shares at an average $119.96 ($1,799,443)
  14. 4 Planned sale Director sold 15,000 shares at an average $117.80 ($1,766,972)
  15. 4 Planned sale Director sold 15,000 shares at an average $122.84 ($1,842,651)
  16. 4 Planned sale President sold 15,000 shares at $121.12 ($1,816,800)
  17. 4 Planned sale Director sold 15,000 shares at an average $117.08 ($1,756,177)
  18. 4 Planned sale Chief Financial Officer sold 689 shares at $118.24 ($81,465)
  19. 4 Planned sale Director sold 15,000 shares at an average $127.22 ($1,908,293)
  20. 4 Planned sale Director sold 15,000 shares at an average $133.57 ($2,003,561)

Page 7 of 54 · 1,067 filings